As one of the world's largest generics and specialty pharmaceutical companies, Mylan's commercial footprint spans more than 150 countries and territories. With a workforce of more than 18,000 employees and external contractors, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.
The company's pharmaceuticals businesses fall into three categories – Generics, Active Pharmaceutical Ingredients and Specialty. Its Generics business is divided further by geography – North America; Europe, the Middle East and Africa; and Asia Pacific.
Mylan's proven ability to operate a global commercial enterprise while demonstrating sensitivity to local market needs positions it well to continue prospering in the highly competitive global generics and specialty pharmaceutical industry.